MBLI QuickSwitch™ kit technology aims to replicate the immune response by mimicking peptide exchange on an MHC molecule.
Rapid and Reliable Custom Tetramer Generation for T-Cell Staining
How To Choose The Appropriate Nanovesicle
The aim of this post is to explain how to choose the appropriate nanovesicle regarding its final application. Although nanovesicles have a lot of different applications, here we will discuss the most common: Intracellular delivery Controlled delivery In vitro assays In vivo assays Passive
January 2017: The Antibody Update
Mitigating the Reproducibility Crisis in Cancer Drug Research Reproducibility has been highlighted as one of the main problems when validating cancer research. Scientists with the The Reproducibility Project have opted to begin pragmatically reviewing the reproducibility of the research released
December 2016: The Antibody Update
Merck’s Ebola Vaccine is 100% Effective An extremely effective Ebola virus vaccine created by Merck was recently tested in Guinea with 100% effectiveness. Though the vaccine is late for the worst part of the infection, the results are so promising
November 2016: The Antibody Update
China Perform First Injection of CRISPR Modified Cells into a Person Use of CRISPR-Cas9 in human cells for treatment of disease has been a controversial topic amongst scientists since the discovery of the powerful gene editing tool. In this clinical
A Summary of ProSci’s Research on HIV
ProSci‘s roots lie in the research of Human Immunodefficiency Virus and working to develop a neutralizing vaccine against it. Below is an “abstract of abstracts” summarizing the research performed over the last several years that has built their business from
July 2016: The Antibody Update from ProSci
This months ProSci Antibody Update’s news includes the discovery of a new MRSA antibiotic found in the nose, the newest map of the human brain, and the discovery of a neutralizing antibody against the highly conserved HA stalk of inluenza.
April 2016: The Antibody Update
This months ProSci news features a new study on broadly neutralizing antibodies long term treatment of HIV, where the first reported Zika Virus death in US territory occured, and a fully human polyclonal antibodies against Ebola-Z. Broadly Neutralizing Antibodies Prevent
Antibody Suppresses AIDS Virus
News from ProSci: Results from a new trial found that an “extremely potent” antibody can dramatically reduce the level of the HIV virus in a patient’s blood. An H9 T cell, blue, is shown infected with HIV, yellow. Researchers at